Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

Bupa - SWOT Analysis

Datamonitor, July 2010, Pages: 28


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

The Bupa - SWOT Analysis company profile is the essential source for top-level company data and information. Bupa - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.

Bupa (The British United Provident Association) is a privately held international healthcare group. The group, through its subsidiaries, provides health insurance and health and care services. It also manages and operates care homes, hospitals and clinics. It has operations in more than 200 countries including Spain, Australia, Hong Kong, Thailand, Malta and Saudi Arabia. The group is headquartered in London, the UK and employed 41,898 people as of December 31, 2009. The group recorded revenues of £6,941.4 million (approximately $10,869.7 million-) during the financial year (FY) ended December 2009, an increase of 17.2% over FY2008. The increase in revenues was due to strong performance of Asia Pacific and EMEALA segment. The operating profit of the group was £367.8 million (approximately $575.9 million) during FY2009, an increase of 58.2% over FY2008. The net profit of the group was £288.9 million (approximately $452.4 million) in FY2009, as compared to the net profit of £106.9 million ($167.4 million) in FY2008. - Calculated using the constant conversion rate of £1 = $1.56593 for the financial year ended December 31, 2009.

Scope of the Report

- Provides all the crucial information on Bupa required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Bupa in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Bupa
-Data is supplemented with details on Bupa history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Bupa

Reasons to Purchase

- Support sales activities by understanding your customers’ businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available



Customers who bought this item also bought

Bupa

Bupa - Strategy and SWOT Report

Bupa- Strategy and SWOT Report

Ramsay Health Care Limited - SWOT Analysis

Ramsay Health Care Limited - Strategy and SWOT Report

WH Smith PLC - SWOT Analysis

Reckitt Benckiser Group plc - SWOT Analysis

Coventry Health Care, Inc. - SWOT Analysis

Ramsay Health Care Limited - Strategy and SWOT Report

Netcare Limited - SWOT Analysis



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds